Correction: BRAFV600E -mutated ovarian serous borderline tumors are at relatively low risk for progression to serous carcinoma

Correction: BRAF^V600E -mutated ovarian serous borderline tumors are at relatively low risk for progression to serous carcinoma

Oncotarget. 2021 Jun 22;12(13):1323-1324. doi: 10.18632/oncotarget.28001.

M Herman Chui¹, Susanne K Kjaer^{2

3}, Kirsten Frederiksen², Charlotte G Hannibal², Tian-Li Wang¹, Russell Vang^{1

4

5}, Ie-Ming Shih^{1

4

5}

¹ Department of Pathology, The Johns Hopkins University School of Medicine, Baltimore, MD, USA.
² Unit of Virus, Lifestyle and Genes, Danish Cancer Society Research Center, Copenhagen, Denmark.
³ Gynecologic Clinic, Juliane Marie Centre, Copenhagen University Hospital, Copenhagen, Denmark.
⁴ Department of Obstetrics & Gynecology, The Johns Hopkins University School of Medicine, Baltimore, MD, USA.
⁵ These authors have contributed equally to this work.

[This corrects the article DOI: 10.18632/oncotarget.27326.].